PE, hedge funds among Rossari Biotech’s pre-IPO backers as firm trims valuation

Premium

Rossari Biotech Ltd, which will open its initial public offering next week, raised fresh capital from a hedge fund and homegrown private equity investors just weeks before the coronavirus pandemic roiled stock markets in March. The textile speciality chemicals maker will become the first company to float an IPO ever since ......